Annals of neurology
Real-World Effectiveness of Switching to Oral or Infusion Versus Injectable Disease-Modifying Therapy in Pediatric Multiple Sclerosis.
Aaron W Abrams, Michael Waltz, T Charles Casper, Gregory Aaen, Leslie A Benson, Eva-Chava M Bernfeld, Leigh E Charvet, Tanuja Chitnis, Carla Francisco, Mark P Gorman, Jennifer S Graves, Lauren Krupp, Kimberly O'Neill, Timothy E Lotze, Soe Mar
Published: 202510.1002/ana.78086
Abstract
OBJECTIVE: To assess real-world effectiveness of switching disease-modifying therapy (DMT) in pediatric multiple sclerosis (MS) and clinically isolated syndrome (CIS) initially treated with platform injectables on disease activity. METHODS: Of 2615 p…
Preview only. Read the full abstract at the source